Molecular International Prognosis Scoring System for Myelodysplastic Syndromes ASH, December 2021.

Towards a Genetically-Inspired MDS Classification. ASH MDS Foundation Symposium, December 2021.

A clinical-molecular and personalized risk scoring system for patients with myelodysplastic syndromes. EMBL Cancer Genomics, November 2021.

TP53 in myeloid disease: implication of allelic state for genome stability and disease evolution. EHA, June 2021.

Population Genomics and Personalized Prognosis in Myelodysplastic Syndromes. European Bioconductor Meeting, December 2020.

TP53 State Dictates Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes. ASH, December 2019.

Mutational Impact on Diagnostic and Prognostic Evaluation of MDS. ASH MDS Foundation Symposium, December 2018.

A time- and cost-effective clinical diagnosis tool to quantify abnormal splicing from targeted single-gene RNA-seq. Splicing 2016, September 2016.

Deciphering splicing with sparse regression techniques in the era of high-throughput RNA sequencing. Journées MAS, Grande dimension et génomique, August 2016.

A convex formulation for joint RNA isoform detection and quantification from multiple RNA-seq samples. NIPS workshop on Computational Biology (MLCB), December 2014.

Fast isoform detection from RNA-Seq data with network flow techniques. ECCB'14 RADIANT Workshop, September 2014.

Kernel bilinear regression for toxicogenetics. RECOMB Conference on Regulatory and Systems Genomics, with DREAM Challenges, November 2013.

FlipFlop: Fast Lasso based Isoform Prediction as a FLOw Problem. HitSeq, July 2013.

Efficient sparse method for RNA isoforms identification and quantification from RNA-seq data with network flows. NIPS workshop on Computational Biology (MLCB), December 2012.